229 related articles for article (PubMed ID: 11375247)
1. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.
Miyata N; Taniguchi K; Seki T; Ishimoto T; Sato-Watanabe M; Yasuda Y; Doi M; Kametani S; Tomishima Y; Ueki T; Sato M; Kameo K
Br J Pharmacol; 2001 Jun; 133(3):325-9. PubMed ID: 11375247
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor.
Sato M; Ishii T; Kobayashi-Matsunaga Y; Amada H; Taniguchi K; Miyata N; Kameo K
Bioorg Med Chem Lett; 2001 Dec; 11(23):2993-5. PubMed ID: 11714595
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.
Seki T; Wang MH; Miyata N; Laniado-Schwartzman M
Biol Pharm Bull; 2005 Sep; 28(9):1651-4. PubMed ID: 16141533
[TBL] [Abstract][Full Text] [Related]
4. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
6. Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine.
Wang MZ; Wu JQ; Bridges AS; Zeldin DC; Kornbluth S; Tidwell RR; Hall JE; Paine MF
Drug Metab Dispos; 2007 Nov; 35(11):2067-75. PubMed ID: 17709372
[TBL] [Abstract][Full Text] [Related]
7. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
Gentile DM; Verhoeven CH; Shimada T; Back DJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):975-82. PubMed ID: 9864282
[TBL] [Abstract][Full Text] [Related]
8. Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation.
Mu Y; Klamerus MM; Miller TM; Rohan LC; Graham SH; Poloyac SM
Drug Metab Dispos; 2008 Nov; 36(11):2324-30. PubMed ID: 18725506
[TBL] [Abstract][Full Text] [Related]
9. Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
Mišir M; Renić M; Novak S; Mihalj M; Ćosić A; Vesel M; Drenjančević I
Exp Physiol; 2017 Dec; 102(12):1596-1606. PubMed ID: 28940693
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury.
Yousif MH; Benter IF; Roman RJ
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):33-41. PubMed ID: 19302554
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
[TBL] [Abstract][Full Text] [Related]
12. Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats.
Toth P; Csiszar A; Sosnowska D; Tucsek Z; Cseplo P; Springo Z; Tarantini S; Sonntag WE; Ungvari Z; Koller A
Br J Pharmacol; 2013 Apr; 168(8):1878-88. PubMed ID: 23194285
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
14. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes.
Ren S; Yang JS; Kalhorn TF; Slattery JT
Cancer Res; 1997 Oct; 57(19):4229-35. PubMed ID: 9331082
[TBL] [Abstract][Full Text] [Related]
16. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
Hyland R; Roe EG; Jones BC; Smith DA
Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
Grimm SW; Dyroff MC
Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
Rifkind AB; Lee C; Chang TK; Waxman DJ
Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
[TBL] [Abstract][Full Text] [Related]
19. Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A.
Guo M; Roman RJ; Falck JR; Edwards PA; Scicli AG
J Pharmacol Exp Ther; 2005 Nov; 315(2):526-33. PubMed ID: 16081682
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]